Eubelius advised WDP on the deal, while the underwriters were represented by Stibbe. WDP raised EUR 300 million through an accelerated bookbuild (ABB) with institutional investors....
WDP’s €300 Million Accelerated Bookbuild
Zealand Pharma’s DKK 786 Million Shares Private Placement
Kromann Reumert has assisted Danske Bank A/S, Goldman Sachs International and Nordea Danmark, Filial af Nordea Bank Abp, Finland, which acted as Joint Global Coordinators and...
BioInvent’s Shares Offering
Baker McKenzie acted as legal advisor to Kempen & Co and Pareto Securities on the deal. BioInvent International has carried out a primary issuance of shares...
SynAct Pharma’s SEK 150 Million Preferential Rights Offering
Baker McKenzie acted as legal advisor to the Joint Global Coordinators with an international Capital Markets, while Setterwalls has advised SynAct Pharma AB . SynAct Pharma...
IO Biotech’s $100.1 Million Initial Public Offering
Latham & Watkins represented the underwriters in the IPO. IO Biotech, Inc. has announced the pricing of its initial public offering of 7,150,000 shares of its common...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
Immunicum’s SEK 141.2 Million Share Issue
Cederquist has advised Immunicum AB on the deal, while Baker McKenzie acted as legal advisor to the Joint Bookrunners. Immunicum AB successfully completed a directed share...
Compleo Charging Solutions AG’s €23.8 Million Capital Increase
Noerr has advised the underwriters COMMERZBANK, Kempen & Co. and ODDO BHF on the deal. Compleo Charging Solutions AG resolved to implement capital increase against cash...
Y-mAbs Therapeutics’ $115 Million Follow-On Public Offering
Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
Achilles Therapeutics’ $175.5 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing...
CTP N.V.’s EUR 854 Million Initial Public Offering
Clifford Chance advised the syndicate of banks (Erste Group, Goldman Sachs, Morgan Stanley, Kempen & Co UBS, ING and Raiffeisen Bank) on the offering and listing...